Immtech Pharmaceuticals signed a Memorandum of Understanding with Beijing Capital Medical University (BCMU) to establish a joint venture that provides contract research services (CRS) in China. The joint venture will provide drug discovery services. Immtech is a newcomer to the CRS/CRO space. Its traditional focus has been on drug development. More details...

Stock Symbol: (AMEX: IMM)